All Posts By

Smartkarma Daily Briefs

Daily Brief TMT/Internet: Scsk Corp, Chroma Ate Inc, Groww, Pony AI, NVIDIA Corp, Fiserv, SK Hynix, Mobileye Global and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • SCSK Corp (9719 JP): Sumitomo (8053 JP)’s Attractive Tender Offer at JPY5,700
  • SCSK Corp (9719 JP): Sumitomo (8053 JP)’s Rumoured Privatisation Offer
  • Chroma Ate (2360 TT): Double Index Inclusion Coming Up with Plenty to Buy
  • Groww IPO: Growwing Fast; Index Inclusions Will Be Sloww; Small Floww
  • Pony.AI Hong Kong IPO Preview
  • Nvidia Jensen’s $500bn: What Did He Say Exactly? What Does It Mean for Supply Chain Forecasts?
  • Fiserv Inc (FI) – Wednesday, Jul 30, 2025
  • SK Hynix Q325. HBM, DRAM, NAND All Sold Out Through 2026
  • Primer: SK Hynix (000660 KS) – Oct 2025
  • Mobileye’s Next Big Leap: Inside the Race to Launch Eyes-Off Cars by 2027!


SCSK Corp (9719 JP): Sumitomo (8053 JP)’s Attractive Tender Offer at JPY5,700

By Arun George

  • In response to the Nikkei report, Scsk Corp (9719 JP) has recommended a tender offer from Sumitomo Corp (8053 JP) at JPY5,700, a 31.5% premium to the last close.
  • The offer is attractive compared to precedent transactions, is above the midpoint of the IFA DCF valuation range and represents an all-time high. 
  • An attractive offer facilitates deal completion. The tender runs from 30 October to 12 December, with payment commencing from 19 December.

SCSK Corp (9719 JP): Sumitomo (8053 JP)’s Rumoured Privatisation Offer

By Arun George

  • Today, the Nikkei reported that Sumitomo Corp (8053 JP) plans to privatise Scsk Corp (9719 JP) through a tender offer. Both shares were placed on a trading halt.
  • The Nikkei states that the total acquisition cost would be around JPY800 billion, based on an arbitrary assumption that the offer will be around 20% above the undisturbed price.
  • The privatisation is strategically sensible. The rumoured offer price of JPY5,109.60 is attractive compared to peer multiples and would represent an all-time high. 

Chroma Ate (2360 TT): Double Index Inclusion Coming Up with Plenty to Buy

By Brian Freitas

  • A massive rally in Chroma Ate Inc (2360 TT) should see the stock added to a global index in November and then to another country ETF in December.
  • With one exception, Chroma Ate Inc (2360 TT) has outperformed its peers over the last 6 months. With large buying to come, that could continue in the short-term.
  • There is positioning in Chroma Ate Inc (2360 TT) and its peers. With continued momentum in the stock, the path of least resistance is higher.

Groww IPO: Growwing Fast; Index Inclusions Will Be Sloww; Small Floww

By Brian Freitas

  • Groww (1573648D IN) is looking to list on the exchanges by selling 663.23m shares via a primary and secondary offering to raise US$752m at a valuation of US$7bn.
  • The price band has been set at INR 95-100/share, and the issue is likely to price at the top end of the range.
  • The stock will not get Fast Entry to global indices. Inclusion at regular rebalances will commence in June 2026 but flow will be small given the low float.

Pony.AI Hong Kong IPO Preview

By Douglas Kim

  • Pony.ai is getting ready to complete its IPO in Hong Kong in the coming weeks. Pony.ai is one of the leading autonomous driving companies in China. 
  • Pony.ai plans to sell 41.96 million Class A shares under its global offering in Hong Kong, including 4.2 million shares for Hong Kong retail investors.
  • The maximum offer price of the Hong Kong IPO is HK$180 (US$23) per share, which could value the company at more than US$10 billion.

Nvidia Jensen’s $500bn: What Did He Say Exactly? What Does It Mean for Supply Chain Forecasts?

By Nicolas Baratte

  • Nvidia CEO said he has a $500bn AI order book. If over the next 7 quarters, it means growth will remain at ~60% YoY till Apr-27. No slowdown. That’s possible.
  • If it’s over the next 5 quarters (which is what he actually said), it’s enormous growth reaching ~200% YoY in 2H26. I doubt that the supply chain can do that.
  • Consensus is the lowest with most room for upside: Memory stocks. Consensus too low by ~20%: Nvidia. Just a it too low: TSMC.

Fiserv Inc (FI) – Wednesday, Jul 30, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Fiserv is a leading global technology provider in financial services, serving over 1,000 institutions and excelling in multiple sectors.
  • The company has achieved nearly 40 years of double-digit adjusted EPS growth and is well-positioned for continued expansion.
  • Investor focus on Clover’s GPV growth has overshadowed other business strengths, causing market reactions that reflect a disconnect in perception.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


SK Hynix Q325. HBM, DRAM, NAND All Sold Out Through 2026

By William Keating

  • SK Hynix reported Q325 revenues of ₩34.45 trillion, up +10% QoQ and up 39% YoY representing an all time quarterly revenue record
  • Now given the customers demand and the company’s capacity for next year not only HBM but DRAM and NAND capacity has essentially been sold out.
  • DRAM margin could rise closer to HBM but the company does not plan to immediately adjust the capacity mix based on what can be a short-lived change in profitability

Primer: SK Hynix (000660 KS) – Oct 2025

By αSK

  • SK Hynix is exceptionally well-positioned to capitalize on the artificial intelligence supercycle, driven by its market-leading position in High Bandwidth Memory (HBM), a critical component for AI accelerators.
  • The company is experiencing a period of record financial performance, with surging revenue and profitability fueled by insatiable HBM demand and a broader recovery in the DRAM and NAND markets.
  • While facing intensified competition from rivals Samsung and Micron, SK Hynix is aggressively investing in next-generation technologies (HBM4, AI-NAND) and expanding production capacity to solidify its competitive advantages and meet future demand.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Mobileye’s Next Big Leap: Inside the Race to Launch Eyes-Off Cars by 2027!

By Baptista Research

  • Mobileye’s earnings call for the third quarter of 2025 presents a nuanced picture of the company’s current state and future prospects.
  • The company reported $504 million in revenue, showing a 4% year-over-year increase driven by an 8% growth in EyeQ volumes, despite only a modest 1% growth in overall vehicle production among its top customers.
  • Operating cash flow for the quarter was robust at $167 million and has reached nearly $500 million year-to-date, reflecting a notable 150% year-over-year increase.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: ANE Cayman Inc, SK Square , BETA Technologies, CIMC Enric Holdings, Vicor Corp, Greaves Cotton, Transunion, Trueblue Inc, Union Pacific and more

By | Daily Briefs, Industrials

In today’s briefing:

  • ANE (9956 HK): Centurium/Temasek’s Clean Offer
  • SK Square: Selling Its Stake in 11st to SK Planet
  • BETA Technologies (BETA): Electric Aircraft Maker Revenue Tail Intrigues IPO Investors
  • CIMC Enric (3899 HK): A Laggard That Is Poised to Revive
  • Vicor’s AI Goldmine: Why the Stock Is on Fire?
  • Greaves Cotton Limited- Revving Up
  • Primer: SK Square (402340 KS) – Oct 2025
  • TransUnion’s Recent Growth Story: How It’s Winning in Insurance, Marketing, & Communications!
  • Trueblue Inc (TBI) – Thursday, Jul 31, 2025
  • Union Pacific Adapts & Conquers: How It’s Turning Market Shifts Into Growth Opportunities!


ANE (9956 HK): Centurium/Temasek’s Clean Offer

By David Blennerhassett

  • After ANE Cayman Inc (9956 HK), a road freight transportation play, was suspended pursuant to the Takeovers Code, an Offer from PE outfit Centurium Partners, a pre-IPO investor, was expected. 
  • And this is what unfolded. Centurium, together with Temasek and Singapore-based asset manager True Light, are offering HK$12.18/share (best & final) via a Scheme, a 48.54% premium to undisturbed.
  • A scrip alternative is present (mix & match). This is a pre-conditional Offer: it requires SAMR signing off. The FA is JPM. This should help smooth over the reg process.

SK Square: Selling Its Stake in 11st to SK Planet

By Douglas Kim

  • On 29 October, SK Square announced that it is selling its stake in 11st to SK Planet. This is likely to have a slightly negative impact on SK Square.
  • Given SK Planet’s limited financial resources, it is likely that SK Square will provide funding to SK Planet through a capital increase.
  • However, the biggest factor driving SK Square’s share price right now is the continued surge in SK Hynix’s share price. 

BETA Technologies (BETA): Electric Aircraft Maker Revenue Tail Intrigues IPO Investors

By IPO Boutique

  • Each aircraft is projected to produce roughly $13 million in lifetime revenue at a 50% margin, driven largely by recurring battery replacement and service contracts.
  • There are $300 million in anchor orders and a 5% directed share program. The deal is reportedly more than 10-times oversubscribed, according to our sources.
  • The potential for Beta Technologies as a company is immense in a market with few operators. The critical story surrounding the recurring battery-driven economics makes this IPO highly-intriguing.

CIMC Enric (3899 HK): A Laggard That Is Poised to Revive

By Osbert Tang, CFA

  • While CIMC Enric Holdings (3899 HK)‘s share price has lagged YTD, its 3Q25 and 9M25 results look decent with 6.2% and 12.9% YoY increase, respectively.
  • Its backlog orders amount of Rmb30.8bn, up by 10.9% YoY, is a record high. This is already enough to cover the full-year FY26 projected revenue.
  • With a 13.4% 3-year EPS CAGR, its PERs are inexpensive. Meanwhile, it is in an excellent position to thrive under China’s 15th Five-Year Plan (2026-2030).

Vicor’s AI Goldmine: Why the Stock Is on Fire?

By Baptista Research

  • Vicor Corporation surged 27% in a single session to $82.64, following a bullish Q3 2025 earnings report, rapid expansion of its IP licensing business, and deepening engagements with hyperscalers and AI chipmakers.
  • With net income more than doubling year-over-year and licensing revenue on track to exceed $200 million annually, Vicor is increasingly being recognized not just as a power module manufacturer but as a dual-engine IP and hardware company riding the AI wave.
  • Analysts from Needham and Craig-Hallum upgraded the stock, citing its growing relevance in AI data center infrastructure and the monetization of its patented power delivery technologies.

Greaves Cotton Limited- Revving Up

By Nitin Mangal

  • Greaves Cotton (GRV IN) has evolved from a traditional diesel engine manufacturer into a comprehensive fuel-agnostic mobility and engineering solutions provider.  
  • Greaves Electric Mobility Ltd (GEML) (1295040D IN) its subsidiary (known by its flagship brand ‘Ampere’) plans to come out with an IPO of INR 10 bn and an offer-for-sale.
  • Regarding forensics, we draw comfort from the Management’s ability to diversify its businesses and make value-accretive acquisitions. However, frequent churn in management warrants attention.

Primer: SK Square (402340 KS) – Oct 2025

By αSK

  • SK Square is a South Korean investment holding company, spun off from SK Telecom in 2021, with a strategic focus on the semiconductor and information and communication technology (ICT) sectors.
  • The company’s intrinsic value and performance are overwhelmingly tied to its cornerstone asset, a significant ~20% stake in SK Hynix, a global leader in the memory semiconductor market.
  • Future value creation is expected to be driven by the performance of SK Hynix, the potential narrowing of its substantial Net Asset Value (NAV) discount, and strategic investments in new growth areas, though it faces high volatility from the semiconductor industry.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


TransUnion’s Recent Growth Story: How It’s Winning in Insurance, Marketing, & Communications!

By Baptista Research

  • TransUnion reported a strong third quarter in 2025, demonstrating impressive growth and operational strides with regard to technology modernization, strategic acquisitions, and enhanced shareholder returns.
  • The company exceeded all key guidance metrics, supporting a cautiously optimistic outlook for the future amid challenges and opportunities.
  • A major highlight of the quarter was TransUnion’s 11% organic constant currency revenue growth, excluding last year’s breach win—a clear indicator of solid underlying business performance.

Trueblue Inc (TBI) – Thursday, Jul 31, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • TrueBlue has faced nearly a decade of revenue decline and rejected multiple acquisition offers from HireQuest, including a $12.60 per share bid.
  • HireQuest is recognized for its superior business model, contrasting with TrueBlue’s ineffective strategies.
  • TrueBlue’s future depends on management-led turnaround efforts or a potential sale, both of which could benefit investors.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Union Pacific Adapts & Conquers: How It’s Turning Market Shifts Into Growth Opportunities!

By Baptista Research

  • Union Pacific delivered a commendable performance in the third quarter of 2025, with notable financial gains tempered by some challenging market conditions.
  • The company reported an adjusted earnings per share of $3.08, reflecting a 12% increase compared to the previous year, driven primarily by core pricing gains and operational efficiencies.
  • This performance was achieved despite a slight decline in volume and modest headwinds due to lower fuel surcharge revenue.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Alibaba, Orkla India Ltd., Shoei Co Ltd, Dollar Industries, Lululemon Athletica, Ford Motor Co, Minth Group Ltd, Dunelm, Neopharm Co Ltd, Newton Golf Company and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Alibaba Group Hldg (BABA) – Wednesday, Jul 30, 2025
  • Orkla India IPO Review: Strong Brands and Valuations Are Not Too Spicy
  • Shoei (7839) – Wednesday, Jul 30, 2025
  • Dollar Industries’ Big Reshuffle: Why It Matters?
  • Lululemon Tackles Pro Sports With NFL Deal—Game-Changer or Gimmick?
  • Ford’s $1 Billion Recovery Mission: What You Need to Know About Its Big Manufacturing Rebound!
  • Minth (425 HK): Keep Going
  • Primer: Dunelm (DNLM LN) – Oct 2025
  • Primer: Neopharm Co Ltd (092730 KS) – Oct 2025
  • NWTG: Newton Golf initiates 10 million ATM equity offering and launches direct-to-consumer platform in Japan.


Alibaba Group Hldg (BABA) – Wednesday, Jul 30, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Alibaba Group (BABA) is currently priced at $120 per ADS, with a projected valuation of $300 per ADS by 2028, indicating a potential upside of 2.5 times.
  • The company’s future valuation is expected to depend on its key segments: Taobao and Tmall Group in the China e-commerce market and Alicloud, which are currently undervalued.
  • BABA’s low forward multiple of 11-12 times next year’s earnings, along with revenue growth from Alicloud and potential stock buybacks, suggests downside protection for investors.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Orkla India IPO Review: Strong Brands and Valuations Are Not Too Spicy

By Himanshu Dugar

  • Orkla India owns two popular Indian food product brands ‘MTR’ and ‘Eastern that offer Ready to Cook/Eat products as well as pure and blended spices.
  • Both its brands enjoy strong brand heritage in India as well as countries with a higher proportion of the Indian diaspora.
  • IPO is being valued at TTM PE of 40x (lower end of 35-90x ascribed to Indian FMCGs). With a low double-digit growth profile and high ROCEs, valuations look reasonable.

Shoei (7839) – Wednesday, Jul 30, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Shoei, a Japanese company, has been producing premium motorcycle helmets since 1960, known for quality in fit, comfort, and noise reduction.
  • The company holds a 60% market share in the premium motorcycle helmet sector, outperforming competitors like AGV and Bell.
  • Shoei generates significant sales, with 45% from Europe, and has shown solid financial growth with a 3% unit volume CAGR and a 10% revenue CAGR from 2016 to mid-2025.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Dollar Industries’ Big Reshuffle: Why It Matters?

By Sudarshan Bhandari

  • Dollar Industries (DOLLAR IN) has announced a Composite Scheme of Arrangement, merging eight promoter group companies and demerging one hosiery business undertaking into the listed entity.
  • The scheme fundamentally restructures DIL, consolidating brand ownership, key manufacturing assets, and operational real estate, directly addressing long-standing concerns regarding related-party transactions and corporate complexity.
  • While execution risks persist, the strategic clarity and governance enhancement resulting from this vertical integration could serve as a powerful catalyst, potentially driving a valuation re-rating.

Lululemon Tackles Pro Sports With NFL Deal—Game-Changer or Gimmick?

By Baptista Research

  • Lululemon Athletica is making its most ambitious leap yet into professional sports apparel with a new licensed collection for all 32 NFL teams.
  • The move marks the brand’s first-ever partnership with the National Football League and is aimed at diversifying its consumer base while reigniting sluggish U.S. sales.
  • The collection—available on Fanatics.com, NFLShop.com, and at team stadium stores—includes men’s and women’s gear from Lululemon’s signature styles such as Steady State, Define, Scuba, and Align.

Ford’s $1 Billion Recovery Mission: What You Need to Know About Its Big Manufacturing Rebound!

By Baptista Research

  • Ford Motor Company’s third-quarter 2025 earnings presentation highlighted several areas of strength and challenge within the business.
  • The company reported a record $50.5 billion in revenue and $2.6 billion in adjusted EBIT, despite encountering significant headwinds due to tariff impacts and an operational disruption caused by a Novelis plant fire.
  • The revenue growth, driven by strong product offerings such as the iconic F-150 and Mustang, showcases Ford’s solid market position in both traditional vehicles and its developing lineup of electric vehicles (EVs).

Minth (425 HK): Keep Going

By Henry Soediarko

  • After the good run, Minth Group Ltd (425 HK) share price looks a bit expensive. 
  • However, it was a value stock before, trading at 0.6x book value while growth remains. 
  • Compared to its peers, it is still not too expensive and the growth seem to continue as the company is able to expand its margin. 

Primer: Dunelm (DNLM LN) – Oct 2025

By αSK

  • Market Leader with Room to Grow: Dunelm is the UK’s leading homewares retailer with a market share of 11.5%, yet it only holds 7.7% of the combined homewares and furniture market, indicating significant headroom for growth in a large and fragmented sector.
  • Resilient Financial Performance Amidst a Challenging Market: Despite a soft consumer market and inflationary pressures, the company has demonstrated volume-driven sales growth, improved gross margins, and maintained strong cash generation, showcasing the strength of its low-cost, vertically integrated business model.
  • Strategic Focus on Omnichannel and Value Proposition: Management’s clear strategy is centered on a ‘Total Retail System’ that integrates its 180+ stores with a growing online presence (36% of sales), and a value-for-money proposition that resonates with a broad customer base, driving customer acquisition and market share gains.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Neopharm Co Ltd (092730 KS) – Oct 2025

By αSK

  • Proprietary Technology Driving Brand Strength: Neopharm’s core competitive advantage lies in its patented Multi-Lamellar Emulsion (MLE) technology, which mimics the natural lipid structure of the skin. This scientifically-backed technology underpins its key brands like Atopalm and Real Barrier, fostering strong brand loyalty, particularly in the sensitive and dry skin segments.
  • Favorable Industry Tailwinds: The global dermo-cosmetics market is experiencing robust growth, with forecasts projecting a CAGR of 7.4% to 11.1%. This expansion is driven by rising consumer awareness of skin health, an increasing prevalence of skin conditions, and a growing demand for scientifically-backed, therapeutic cosmetic solutions.
  • Solid Financials and Shareholder Returns: The company has demonstrated a strong track record of revenue and net income growth over the past decade. This financial strength is complemented by a commitment to shareholder returns, evidenced by a consistently increasing dividend per share and a dividend yield that has grown significantly over the last three years.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


NWTG: Newton Golf initiates 10 million ATM equity offering and launches direct-to-consumer platform in Japan.

By Zacks Small Cap Research

  • Newton Golf (NASDAQ: NWTG) is an innovative, technology driven golf company with a growing portfolio of golf products, including putters, golf shafts, golf grips, and other golf-related accessories.
  • The company went public in August 2023 raising $11.6 million in net proceeds.
  • The company announced its entry into the golf shaft market in November 2023.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Cipla Ltd, Bavarian Nordic A/S, Johnson & Johnson, Avacta, Align Technology, West Pharmaceutical Services Inc, Hangzhou Diagens Biotechnology, Intellia Therapeutics , Samsung Biologics and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Cipla-Eli Lilly Deal: Strategic Masterstroke or Margin Mirage?
  • Bavarian Nordic: Final Offer, Tight Math
  • Johnson & Johnson (NYSE: JNJ) To Spin Off Orthopaedics Business
  • Primer: Avacta (AVCT LN) – Oct 2025
  • Align Technology Inc (ALGN) – Wednesday, Jul 30, 2025
  • West Pharmaceutical Services: High-Value Product Components Expansion As A Significant Needle Mover In The Company’s Future Performance!
  • Pre-IPO Hangzhou Diagens Biotechnology – The Turning Point of Medical Imaging AI Has Not Arrived
  • Intellia Therapeutics Stock Plunge: What Does The Safety Scare In Gene-Editing Trials Mean?
  • Samsung Biologics (207940 KS): Momentum Accelerates in 3Q; Solid Order Book; Reaffirms FY Guidance


Cipla-Eli Lilly Deal: Strategic Masterstroke or Margin Mirage?

By Nimish Maheshwari

  • Cipla Ltd (CIPLA IN) signed an exclusive distribution and promotion agreement with Eli Lilly on 23 October 2025 to market tirzepatide under the brand name Yurpeak in India.
  • The deal positions Cipla as a first mover in India’s nascent GLP-1 obesity care segment, projected to grow 40x by 2030.
  • Financially modest but strategically transformative, the deal anchors Cipla’s entry into obesity therapeutics and sets the stage for a broader GLP-1 platform spanning branded and generic drugs.

Bavarian Nordic: Final Offer, Tight Math

By Jesus Rodriguez Aguilar

  • Bidders Nordic Capital and Permira raised their offer to DKK 250/share (from DKK 233), but ATP’s 10% block and limited irrevocables complicate closing.
  • Gross spread has widened to 5.71% (DKK 236.5 close on 28 Oct), reflecting rising uncertainty. Implied success probability is now ~76.5%.
  • High upside if completed, but downside risk remains to pre-deal levels (DKK 192.5). Time to settlement is short, pushing annualized return to ~151%.

Johnson & Johnson (NYSE: JNJ) To Spin Off Orthopaedics Business

By Garvit Bhandari

  • Separation should unlock value by allowing J&J to double-down on high-growth, higher-margin MedTech and pharma businesses.
  • SpinCo will emerge as one of the world’s largest pure-play orthopaedics firm with ~$9B revenue and global leadership across hips, knees, and trauma.
  • We see valuation upside. Transaction is likely to enhance JNJ’s sum-of-the-parts value.

Primer: Avacta (AVCT LN) – Oct 2025

By αSK

  • Avacta is transitioning into a pure-play oncology biotechnology company, centered on its proprietary pre|CISION™ and Affimer® platforms, designed to improve the safety and efficacy of cancer therapies.
  • The lead asset, AVA6000, a tumor-activated doxorubicin, has demonstrated a favorable safety profile and promising anti-tumor activity in its Phase 1 clinical trials, particularly in salivary gland cancer, providing clinical proof-of-concept for the pre|CISION™ platform.
  • The company is strategically divesting its diagnostics division to extend its cash runway and focus resources on advancing its oncology pipeline, which includes next-generation peptide drug conjugates (PDCs) and Affimer® drug conjugates (AffDCs).

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Align Technology Inc (ALGN) – Wednesday, Jul 30, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Align Technology Inc. (ALGN) is poised for a resurgence with a favorable reward/risk ratio post-Covid.
  • The company primarily operates through its Clear Aligner segment, with Invisalign accounting for 81% of operating profit.
  • Invisalign’s competitive edge includes efficiency, superior technology, and a strong market presence, particularly in the Americas.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


West Pharmaceutical Services: High-Value Product Components Expansion As A Significant Needle Mover In The Company’s Future Performance!

By Baptista Research

  • West Pharmaceutical Services delivered solid third-quarter results for 2025, showing noteworthy improvements across key metrics.
  • The company reported revenues of $805 million, marking a 5% organic increase, which exceeded their internal expectations.
  • The adjusted operating margin was 21.1%, while the adjusted EPS increased by 6% to $1.96 compared to the previous year.

Pre-IPO Hangzhou Diagens Biotechnology – The Turning Point of Medical Imaging AI Has Not Arrived

By Xinyao (Criss) Wang

  • The willingness of hospitals/patients to purchase medical AI products/services is still not strong enough. The real turning point for the commercialization of medical AI hasn’t arrived yet.
  • The small revenue scale reflects that Diagens’ products have not received widespread recognition from the medical system. Market education cost would be high, leading to increasing selling and distribution expenses
  • Valuation should be higher than Basecare (2170 HK) who just focuses on testing kits in assisted reproduction, but should be lower than Xunfei Healthcare, who has better commercialization performance/channels advantage.

Intellia Therapeutics Stock Plunge: What Does The Safety Scare In Gene-Editing Trials Mean?

By Baptista Research

  • Intellia Therapeutics shares nosedived by 40% on October 27, 2025, after the company abruptly paused two critical Phase 3 clinical trials for its lead gene-editing candidate, nex-z.
  • The suspension follows the hospitalization of an elderly patient treated with nex-z who experienced elevated liver enzymes and bilirubin levels—early markers of liver injury.
  • This development casts a dark cloud over nex-z, a therapy that had been projected to drive 62% of Intellia’s estimated 2030 revenues and was central to the company’s valuation narrative.

Samsung Biologics (207940 KS): Momentum Accelerates in 3Q; Solid Order Book; Reaffirms FY Guidance

By Tina Banerjee

  • Samsung Biologics (207940 KS) reported revenue of KRW1,660B (up 40% YoY and 29% QoQ) and operating profit of KRW729B (up 115% YoY and 53% QoQ) in 3Q25.
  • In 3Q25, the company continued to secure new manufacturing and development contracts with global pharmaceutical partners, bringing its cumulative contract volume to over $20B since its founding. 
  • Amid steady client demand and efficient capacity utilization, Samsung Biologics is confident on achieving full-year revenue growth guidance of 25–30% YoY, as revised upward in last quarter.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: AUB Group Limited, James River Group Holdings, Mbia Inc, S&P/ASX 200, Entrust Inc, Arealink Co Ltd, Matsui Securities and more

By | Daily Briefs, Financials

In today’s briefing:

  • AUB Group (AUB AU) Opens Books To EQT’s NBIO
  • Primer: James River Group Holdings (JRVR US) – Oct 2025
  • Mbia Inc (MBI GFL 0 ’33) – Wednesday, Jul 30, 2025
  • S&P/ASX 200 Outlook: Buy the Pullback or Sell?
  • Entrust Inc (7191 JP): 1H FY03/26 flash update
  • Arealink Co Ltd (8914 JP): Q3 FY12/25 flash update
  • Matsui Securities (8628 JP): 1H FY03/26 flash update


AUB Group (AUB AU) Opens Books To EQT’s NBIO

By David Blennerhassett

  • AUB Group Limited (AUB AU), which operates a network of insurance “matchmakers”, has announced a NBIO, via a Scheme, from EQT @ A$45/share, a ~40% premium to undisturbed.
  • That indicative price is up from $43/share proposed on the 13th September (but not made public). 
  • AUB’s board has opted to open its books to EQT, on an exclusive basis, for six weeks. Tentatively, that expires on or around the 9th December. 

Primer: James River Group Holdings (JRVR US) – Oct 2025

By αSK

  • James River is undergoing a significant strategic repositioning, having divested its volatile Casualty Reinsurance segment to focus on its core Excess & Surplus (E&S) Lines and Specialty Admitted Insurance businesses.
  • The company faces considerable challenges, including a history of significant net losses, adverse reserve development, and substantial declines in market capitalization and revenue over multiple years.
  • Despite a challenging financial track record, the company operates in the growing E&S market, which is benefiting from a hard market cycle with elevated premiums and stricter underwriting standards, presenting a potential tailwind.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Mbia Inc (MBI GFL 0 ’33) – Wednesday, Jul 30, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • The author reassesses the MBIA GFL 2033 Notes investment, highlighting a current buy-and-hold opportunity despite previous underperformance.
  • The yield on the notes has risen from 10% to 15%, with a potential 10% internal rate of return achievable for investors.
  • The resolution of the Puerto Rico Electric Power Authority bankruptcy is seen as key to increasing MBIA’s equity value and facilitating a sale.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


S&P/ASX 200 Outlook: Buy the Pullback or Sell?

By Nico Rosti

  • The S&P/ASX 200 (AS51 INDEX) has stalled since mid-August 2025, possibly a consolidation period after the strong gains delivered since Apri. Or maybe it’s about to go down…
  • The index started a modest pullback this week, closing at 8926.20 on Wednesday. That price is just below our model Q1 support zone, not oversold yet.
  • We have identified a key support zone that could be used for buy-the-dip strats, but if the index falls below that support, it may have ended its rally (short-term forecast).

Entrust Inc (7191 JP): 1H FY03/26 flash update

By Shared Research

  • Revenue increased by 15.8% YoY to JPY5.9bn, driven by growth in rent guarantee services.
  • Operating profit rose 22.4% YoY to JPY1.4bn, with an operating profit margin of 23.7%.
  • Total contracts in force reached 485,000, with Guarantee business contracts increasing 18.9% YoY to 382,000.

Arealink Co Ltd (8914 JP): Q3 FY12/25 flash update

By Shared Research

  • Overall revenue and profits increased YoY in 1H FY12/25, driven by the Self-Storage segment’s steady performance.
  • Self-Storage segment revenue grew by 16.1% YoY, with a 13.0% YoY increase in total storage units.
  • Land Rights Consolidation segment revenue and profit declined YoY due to business scaling back policy in FY12/25.

Matsui Securities (8628 JP): 1H FY03/26 flash update

By Shared Research

  • Net operating revenue increased 17.0% YoY and 8.4% QoQ to JPY11.6bn, with operating profit at JPY5.6bn.
  • Total commissions rose 13.5% YoY and 16.3% QoQ to JPY6.1bn, driven by brokerage commissions increase.
  • SG&A expenses were JPY6.0bn, up 14.4% YoY, with transaction-related expenses rising 20.1% YoY to JPY1.8bn.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Advantest Corp, Ibiden Co Ltd, Kokusai Electric , Delta Electronics Thailand , JX Advanced Metals, Scsk Corp, ANE Cayman Inc, Sanil Electric, AUB Group Limited, SK Square and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Advantest (6857 JP): Rally Leads to Potential NKY Capping
  • [Japan Special] Ibiden (4062) Replaces Nidec (6594) In Nikkei 225 on Accounting – A VERY BIG DEAL
  • [Japan ECM] Kokusai Elec (6525) – Applied Materials $330mm Selldown
  • SET50 Index Rebalance Preview: Two Changes in Dec, Big DELTA Capping
  • [Quiddity Index] Predictions for the Global Index Provider Rebal in November 2025
  • SCSK Corp (9719 JP): Sumitomo (8053 JP)’s Attractive Tender Offer at JPY5,700
  • ANE (9956 HK): Centurium/Temasek’s Clean Offer
  • Sanil Electric Poised for Pop on Nov 20 KOSPI200 Ad‑Hoc (HD Hyundai Merger)
  • AUB Group (AUB AU) Opens Books To EQT’s NBIO
  • SK Square: Selling Its Stake in 11st to SK Planet


Advantest (6857 JP): Rally Leads to Potential NKY Capping

By Brian Freitas


[Japan Special] Ibiden (4062) Replaces Nidec (6594) In Nikkei 225 on Accounting – A VERY BIG DEAL

By Travis Lundy

  • In June, Nidec Corp (6594 JP) announced they would delay the release of their yuho for three months because of an internal investigation into NIDEC FIR INTERNATIONAL (Italy).
  • In September they launched a special committee. Shares fell 22%. Last Thursday, the company cancelled its interim dividend. Today, the JPX designated Nidec as Security on Special Alert.
  • This is a VERY BIG DEAL. Nikkei225 deletes Nidec 5-Nov-2025, replaced by Ibiden Co Ltd (4062 JP) (PAF 1.0x). Designation also triggers TOPIX deletion for Nidec, likely on 30 October. 

[Japan ECM] Kokusai Elec (6525) – Applied Materials $330mm Selldown

By Travis Lundy


SET50 Index Rebalance Preview: Two Changes in Dec, Big DELTA Capping

By Brian Freitas


[Quiddity Index] Predictions for the Global Index Provider Rebal in November 2025

By Travis Lundy

  • A global index provider will announce its quarterly review on 5 November 2025. The rebalance will take place on 24 November 2025.
  • We make predictions every week for the following index rebalance and publish them along with predictions for 100 other indices. 
  • This insight shows our whole set of predictions across 47 countries for the next rebalance. Most of these names are unchanged since our early September predictions. 

SCSK Corp (9719 JP): Sumitomo (8053 JP)’s Attractive Tender Offer at JPY5,700

By Arun George

  • In response to the Nikkei report, Scsk Corp (9719 JP) has recommended a tender offer from Sumitomo Corp (8053 JP) at JPY5,700, a 31.5% premium to the last close.
  • The offer is attractive compared to precedent transactions, is above the midpoint of the IFA DCF valuation range and represents an all-time high. 
  • An attractive offer facilitates deal completion. The tender runs from 30 October to 12 December, with payment commencing from 19 December.

ANE (9956 HK): Centurium/Temasek’s Clean Offer

By David Blennerhassett

  • After ANE Cayman Inc (9956 HK), a road freight transportation play, was suspended pursuant to the Takeovers Code, an Offer from PE outfit Centurium Partners, a pre-IPO investor, was expected. 
  • And this is what unfolded. Centurium, together with Temasek and Singapore-based asset manager True Light, are offering HK$12.18/share (best & final) via a Scheme, a 48.54% premium to undisturbed.
  • A scrip alternative is present (mix & match). This is a pre-conditional Offer: it requires SAMR signing off. The FA is JPM. This should help smooth over the reg process.

Sanil Electric Poised for Pop on Nov 20 KOSPI200 Ad‑Hoc (HD Hyundai Merger)

By Sanghyun Park

  • HD Hyundai merger: both legs in index, Mipo delists, slot opens — one new name gets added to KOSPI200 via ad‑hoc.
  • Sanil Electric (062040 KS) to replace HD Mipo pre‑Dec review. If DTV settles back into the 500–600k range, then KS200 ETFs will need to scoop ~0.3–0.4x DTV on Nov 26.
  • Better to front‑run KRX; with AI power trade still hot, Nov 20 announcement likely sparks outsized price action vs waiting for rebalance print.

AUB Group (AUB AU) Opens Books To EQT’s NBIO

By David Blennerhassett

  • AUB Group Limited (AUB AU), which operates a network of insurance “matchmakers”, has announced a NBIO, via a Scheme, from EQT @ A$45/share, a ~40% premium to undisturbed.
  • That indicative price is up from $43/share proposed on the 13th September (but not made public). 
  • AUB’s board has opted to open its books to EQT, on an exclusive basis, for six weeks. Tentatively, that expires on or around the 9th December. 

SK Square: Selling Its Stake in 11st to SK Planet

By Douglas Kim

  • On 29 October, SK Square announced that it is selling its stake in 11st to SK Planet. This is likely to have a slightly negative impact on SK Square.
  • Given SK Planet’s limited financial resources, it is likely that SK Square will provide funding to SK Planet through a capital increase.
  • However, the biggest factor driving SK Square’s share price right now is the continued surge in SK Hynix’s share price. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Australia: AUB Group Limited, Pilbara Minerals, Readcloud Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • AUB Group (AUB AU): EQT’s NBIO at A$45.00
  • Valuation vs Sentiment For Pilbara Minerals
  • Readcloud Ltd – Australian schools proving the growth engine


AUB Group (AUB AU): EQT’s NBIO at A$45.00

By Arun George

  • In response to an AFR article, AUB Group Limited (AUB AU) confirmed that on 26 September, it received a non-binding proposal from EQT (EQT SS) at A$45.00.
  • While the offer represents an all-time high, it is arguably light compared to precedent transactions and peer multiples. EQT’s history of unsuccessful ASX tilts warrants some caution. 
  • The Board has granted a six-week exclusive due diligence period, which ends on 20 November. The shareholder structure reduces the vote risk. 

Valuation vs Sentiment For Pilbara Minerals

By FNArena

  • The US-Australia critical minerals investment agreement has driven lithium miner Pilbara Minerals’ share price on sentiment, well above fundamentals, on most assessments.
  • US-Australia critical minerals deal sends miner share prices surging Pilbara Minerals posts solid September quarter beat Lithium prices remain below new production threshold Most brokers see Pilbara Minerals as overvalued

Readcloud Ltd – Australian schools proving the growth engine

By Research as a Service (RaaS)

  • ReadCloud Limited (ASX:RCL) services the education and training sectors through the provision of digital learning content, proprietary interactive technology and support for students and educators.
  • The company released its 4C September quarter activities report and a trading update containing data points for its upcoming FY25 full year result (September year-end).
  • The company delivered a solid result in what is a seasonally quiet last quarter resulting in FY25 unaudited revenue of $12.9m (directly in line with RaaS forecast), representing 4.9% growth over FY24.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Hanmi Semiconductor, SK Hynix and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Introducing the Unusual Policy Narrative Now Pushed: Korea–Japan Economic Integration
  • SK Hynix 3Q25: Another Stunning Quarter. More Upside in 2026.


Introducing the Unusual Policy Narrative Now Pushed: Korea–Japan Economic Integration

By Sanghyun Park

  • Chey Tae‑won’s Korea–Japan integration push is fresh tape—unpriced and unconsumed—unlike the exhausted dividend tax story, making it the real policy‑momentum trade to watch.
  • Korea’s export model is fading, but a $6T Korea–Japan bloc plus CPTPP buzz offers a fresh policy‑momentum catalyst, with AI/data angles luring incremental global flows.
  • Korea–Japan cooperation isn’t a real bloc yet, but it trades like a policy theme—Chey’s 3PRO push makes it a headline‑driven short‑term play ripe for desks.

SK Hynix 3Q25: Another Stunning Quarter. More Upside in 2026.

By Nicolas Baratte

  • SK hynix reported another stunning quarter: revenue up 39% YoY, Operating Profit up 62%
  • The soft guidance for 2026 points to increasing bit growth and we know that ASP are increasing. As SK hynix says “explosive AI growth”.  
  • Best 2 Memory stocks 1. SK hynix 2. Micron.  Samsung? we still need a bit more clarity on HBM3E / 4  qualifications

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Krungthai Card, Delta Electronics Thailand , Thai Oil Pcl and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Thai Pledged Shares: The Prakitchaiwattana Complex Remains Static
  • SET50 Index Rebalance Preview: Two Changes in Dec, Big DELTA Capping
  • Lucror Analytics – Morning Views Asia


Thai Pledged Shares: The Prakitchaiwattana Complex Remains Static

By David Blennerhassett


SET50 Index Rebalance Preview: Two Changes in Dec, Big DELTA Capping

By Brian Freitas


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Thai Oil, Genting Berhad, Nickel Industries, Meituan
  • The UST curve twisted flatter yesterday, with long-end yields declining on account of a solid auction for 5Y notes. The yield on the 2Y UST rose 1 bp to 3.49%, while the yield on the 10Y UST declined 2 bps to 3.98%.
  • Equities and risk assets gained on optimism over a US-China trade deal expected to be signed later this week.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Ohayo Japan | Trump and Takaichi Ink $550bn Deal and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Ohayo Japan | Trump and Takaichi Ink $550bn Deal
  • Japan Morning Connection: A Sea of Knockout Earnings Set to Send Tech and AI Surging
  • Monday Delight: 27/10/25
  • Singapore Market Roundup (28-Oct-2025): RHB’s Yeo raises HRnetGroup target price to 85 cents.


Ohayo Japan | Trump and Takaichi Ink $550bn Deal

By Mark Chadwick

  • U.S. stocks hit record highs led by AI names as Nvidia surged 5%, PayPal partnered with OpenAI, and OpenAI completed recapitalization; S&P 500 +0.2%, Nasdaq +0.8%. 
  • President Trump announced new projects advancing Japan’s $550 billion U.S. investment, a critical minerals deal, record Japanese energy purchases, and enhanced U.S.-Japan cooperation on industrial and anti-drug initiatives. 
  • Deal boosts industry, energy, tech, and defense; Japanese corporates including Toyota, Mitsubishi, Toshiba, Panasonic, Hitachi, Murata, SoftBank, TDK, Fujikura, and JERA benefit.

Japan Morning Connection: A Sea of Knockout Earnings Set to Send Tech and AI Surging

By Andrew Jackson

  • Great numbers from Advantest, Teradyne, Seagate and SK Hynix set to send AI related surging.
  • Jensen Huang spreads NVDA’s net wider while dispelling concerns of a bubble.
  • Qorvo-Skyworks merger could tighten the competitive market for the likes of Murata.

Monday Delight: 27/10/25

By Contrarian Cashflows

  • Each week, I’ll share five intriguing investment ideas that recently caught my attention. These ideas are meant to spark your research and help you kickstart the week ahead with fresh insights.
  • Because these ideas are the result of my first-level idea generation process, they require more in depth research. Therefore, the ideas will often be concise, with occasional references to valuable work from other practitioners that I encourage you to explore.
  • If you have something fascinating to share that could benefit me and the wider community, don’t hesitate to send it my way—I’d love to hear from you!

Singapore Market Roundup (28-Oct-2025): RHB’s Yeo raises HRnetGroup target price to 85 cents.

By Singapore Market Roundup

  • RHB’s Yeo increases HRnetGroup target price to 85 cents.
  • JP Morgan upgrades Keppel REIT and MLT due to lower debt costs and strong demand.
  • Analysts raise iFast’s TPs after record AUA and net profit in 3QFY2025.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars